← FDA DRUG APPROVALS

FDA ANDA · ANDA074906

ACYCLOVIR

Sponsor: ACTAVIS ELIZABETH

APPLICATION
ANDA074906
TYPE
ANDA
ORIGINAL APPROVAL
1997-08-26
LATEST ACTION
2004-10-28
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

ACYCLOVIRDiscontinued
ACYCLOVIR 200MG · CAPSULE · ORAL

Approval history

2004-10-28Labeling · Supplement 14AP
2002-04-23Labeling · Supplement 7AP
2001-11-02Manufacturing (CMC) · Supplement 6AP
2001-05-01Manufacturing (CMC) · Supplement 5AP
2001-03-08Manufacturing (CMC) · Supplement 4AP
2000-07-17Labeling · Supplement 3AP
1998-08-10Labeling · Supplement 2AP
1998-03-26Labeling · Supplement 1AP
1997-08-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →